title: Intranasal apomorphine: a new treatment in Parkinson's disease.
authors.forename: R
authors.initials: R
authors.lastname: Kapoor
authors.forename: N
authors.initials: N
authors.lastname: Turjanski
authors.forename: J
authors.initials: J
authors.lastname: Frankel
authors.forename: B
authors.initials: B
authors.lastname: Kleedorfer
authors.forename: A
authors.initials: A
authors.lastname: Lees
authors.forename: G
authors.initials: G
authors.lastname: Stern
authors.forename: M
authors.initials: M
authors.lastname: Bovingdon
authors.forename: R
authors.initials: R
authors.lastname: Webster
mesh_terms: D000281:Administration, Intranasal; D000368:Aged; D001058:Apomorphine / Q000008:administration & dosage*; D006801:Humans; D008875:Middle Aged; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D001058:Apomorphine